BridgeMD
New treatment option for Lymph Node Neoplasm
Official title LN-RADS, RECIST 1.1 and Node-RADS Classification in the Assessment of Lymph Nodes
ClinicalTrials.gov ID: NCT06527027
What this study is testing
- What it's testing
- The project aims to evaluate the value of the new LN-RADS scales for lymph node classification in CT and MR and to compare this method with two other methods RECIST 1.1 and Node-RADS. The main tested system in the study is LN-RADS, the comparators are RECIST 1.1 and Node-RADS criteria.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- diagnosed or suspected cancer,
- planned lymph node biopsy or lymphadenectomy,
- planned or performed CT/MRI covering an area of the body with lymph nodes, - verified histopathologically or cytologically,
- informed consent to participate in the study.
You likely can't join if
- non-diagnostic CT/MRI images of lymph nodes due to reasons such as movement artifacts, artifacts from metal elements and any other factors that do...
- inconclusive histopathological or cytological results, which do not allow the nodes to be classified into one of two groups - benign or malignant.
The study team makes the final eligibility decision.
Where it's taking place
- Krakow, Poland
- Lodz, Poland
- Warsaw, Poland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Krakow, Poland; Lodz, Poland; Warsaw, Poland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.